-
1
-
-
0037050253
-
The apoptosis promoting bcl-2 homologues bak and nbk/bik overcome drug resistance in mdr-1-negative and mdr-1-overexpressing breast cancer cell lines
-
Radetzki S, Kohne CH, von Haefen C, Gillissen B, Sturm I, Dörken B and Daniel PT (2002) The apoptosis promoting bcl-2 homologues bak and nbk/bik overcome drug resistance in mdr-1-negative and mdr-1-overexpressing breast cancer cell lines. Oncogene 21: 227-238
-
(2002)
Oncogene
, vol.21
, pp. 227-238
-
-
Radetzki, S.1
Kohne, C.H.2
von Haefen, C.3
Gillissen, B.4
Sturm, I.5
Dörken, B.6
Daniel, P.T.7
-
3
-
-
0035901938
-
Overexpression of caspase-3 restores sensitivity for drug-induced apoptosis in breast cancer cells with acquired drug resistance
-
Friedrich K, Wieder T, von Haefen C, Radetzki S, Schulze-Osthoff K, Jänicke R, Dörken B and Daniel PT (2001) Overexpression of caspase-3 restores sensitivity for drug-induced apoptosis in breast cancer cells with acquired drug resistance. Oncogene 20: 2749-2760
-
(2001)
Oncogene
, vol.20
, pp. 2749-2760
-
-
Friedrich, K.1
Wieder, T.2
von Haefen, C.3
Radetzki, S.4
Schulze-Osthoff, K.5
Jänicke, R.6
Dörken, B.7
Daniel, P.T.8
-
4
-
-
0037030465
-
Ceramide induces mitochondrial activation and apoptosis via a bax-dependent pathway in human carcinoma cells
-
von Haefen C, Wieder T, Gillissen B, Stärck L, Graupner V, Dörken B and Daniel PT (2002) Ceramide induces mitochondrial activation and apoptosis via a bax-dependent pathway in human carcinoma cells. Oncogene 21: 4009-4019
-
(2002)
Oncogene
, vol.21
, pp. 4009-4019
-
-
von Haefen, C.1
Wieder, T.2
Gillissen, B.3
Stärck, L.4
Graupner, V.5
Dörken, B.6
Daniel, P.T.7
-
5
-
-
0029928561
-
Apoptotic death of tumor cells correlates with chemosensitivity, independent of p53 or bcl-2
-
Wu GS and El-Deiry WS (1996) Apoptotic death of tumor cells correlates with chemosensitivity, independent of p53 or bcl-2. Clin. Cancer Res. 2: 623-633
-
(1996)
Clin. Cancer Res.
, vol.2
, pp. 623-633
-
-
Wu, G.S.1
El-Deiry, W.S.2
-
6
-
-
0033552638
-
Twenty years of p53 research: Structural and functional aspects of the p53 protein
-
May P and May E (1999) Twenty years of p53 research: structural and functional aspects of the p53 protein. Oncogene 18: 7621-7636
-
(1999)
Oncogene
, vol.18
, pp. 7621-7636
-
-
May, P.1
May, E.2
-
7
-
-
0028987180
-
P53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias
-
Döhner H, Fischer K, Bentz M, Hansen K, Benner A, Cabot G, Diehl D, Schlenk R, Coy J and Stilgenbauer S (1995) P53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias. Blood 85: 1580-1589
-
(1995)
Blood
, vol.85
, pp. 1580-1589
-
-
Döhner, H.1
Fischer, K.2
Bentz, M.3
Hansen, K.4
Benner, A.5
Cabot, G.6
Diehl, D.7
Schlenk, R.8
Coy, J.9
Stilgenbauer, S.10
-
8
-
-
0028172868
-
P53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies
-
Wattel E, Preudhomme C, Hecquet B, Vanrumbeke M, Quesnel B, Dervite I, Morel P and Fenaux P (1994) P53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies. Blood 84: 3148-3157
-
(1994)
Blood
, vol.84
, pp. 3148-3157
-
-
Wattel, E.1
Preudhomme, C.2
Hecquet, B.3
Vanrumbeke, M.4
Quesnel, B.5
Dervite, I.6
Morel, P.7
Fenaux, P.8
-
9
-
-
0028027711
-
Chemosensitivity of lymphocytes from patients with B-cell chronic lymphocytic leukemia to chlorambucil, fludarabine, and camptothecin analogs
-
Silber R, Degar B, Costin D, Newcomb EW, Mani M, Rosenberg CR, Morse L, Drygas JC, Canellakis ZN and Potmesil M (1994) Chemosensitivity of lymphocytes from patients with B-cell chronic lymphocytic leukemia to chlorambucil, fludarabine, and camptothecin analogs. Blood 84: 3440-3446
-
(1994)
Blood
, vol.84
, pp. 3440-3446
-
-
Silber, R.1
Degar, B.2
Costin, D.3
Newcomb, E.W.4
Mani, M.5
Rosenberg, C.R.6
Morse, L.7
Drygas, J.C.8
Canellakis, Z.N.9
Potmesil, M.10
-
10
-
-
0033832590
-
Relapse in childhood acute lymphoblastic leukemia is associated with a decrease of the bax/bcl-2 ratio and loss of spontaneous caspase-3 processing in vivo
-
Prokop A, Wieder T, Sturm I, Essmann F, Seeger K, Wuchter C, Ludwig WD, Henze G, Dörken B and Daniel PT (2000) Relapse in childhood acute lymphoblastic leukemia is associated with a decrease of the bax/bcl-2 ratio and loss of spontaneous caspase-3 processing in vivo. Leukemia 14: 1606-1613
-
(2000)
Leukemia
, vol.14
, pp. 1606-1613
-
-
Prokop, A.1
Wieder, T.2
Sturm, I.3
Essmann, F.4
Seeger, K.5
Wuchter, C.6
Ludwig, W.D.7
Henze, G.8
Dörken, B.9
Daniel, P.T.10
-
11
-
-
0034900902
-
The kiss of death: Promises and failures of death receptors and ligands in cancer therapy
-
Daniel PT, Sturm I, Wieder T and Schulze-Osthoff K (2001) The kiss of death: promises and failures of death receptors and ligands in cancer therapy. Leukemia 15: 1022-1032
-
(2001)
Leukemia
, vol.15
, pp. 1022-1032
-
-
Daniel, P.T.1
Sturm, I.2
Wieder, T.3
Schulze-Osthoff, K.4
-
12
-
-
0034520470
-
Dissecting the pathways to death
-
Daniel PT (2000) Dissecting the pathways to death. Leukemia 14: 2035-2044
-
(2000)
Leukemia
, vol.14
, pp. 2035-2044
-
-
Daniel, P.T.1
-
13
-
-
85047694961
-
Bax expression correlates with cellular drug sensitivity to doxorubicin, cyclophosphamide and chlorambucil but not fludarabine, cladribine or corticosteroids in B cell chronic lymphocytic leukemia
-
Bosanquet AG, Sturm I, Wieder T, Essmann F, Bosanquet MI, Head DJ, Dörken B and Daniel PT (2002) Bax expression correlates with cellular drug sensitivity to doxorubicin, cyclophosphamide and chlorambucil but not fludarabine, cladribine or corticosteroids in B cell chronic lymphocytic leukemia. Leukemia 16: 1035-1044
-
(2002)
Leukemia
, vol.16
, pp. 1035-1044
-
-
Bosanquet, A.G.1
Sturm, I.2
Wieder, T.3
Essmann, F.4
Bosanquet, M.I.5
Head, D.J.6
Dörken, B.7
Daniel, P.T.8
-
14
-
-
0036605086
-
Analysis of p53/bax in primary colorectal carcinoma: Low bax protein expression is a negative prognostic factor in UICC stage III tumors
-
Schelwies K, Sturm I, Grabowski P, Scherbl H, Süchindler I, Hermann S, Stein H, Buhr HJ, Riecken EO, Zeitz M, Dörken B and Daniel PT (2002) Analysis of p53/bax in primary colorectal carcinoma: low bax protein expression is a negative prognostic factor in UICC stage III tumors. Int. J. Cancer 99: 589-596
-
(2002)
Int. J. Cancer
, vol.99
, pp. 589-596
-
-
Schelwies, K.1
Sturm, I.2
Grabowski, P.3
Scherbl, H.4
Süchindler, I.5
Hermann, S.6
Stein, H.7
Buhr, H.J.8
Riecken, E.O.9
Zeitz, M.10
Dörken, B.11
Daniel, P.T.12
-
15
-
-
0344348993
-
Analysis of the p53/bax pathway in colorectal cancer: Low bax is a negative prognostic factor in patients with resected liver metastases
-
Sturm I, Kohne CH, Wolff G, Petrowsky H, Hillebrand T, Hauptmann S, Lorenz M, Dörken B and Daniel PT (1999) Analysis of the p53/bax pathway in colorectal cancer: low bax is a negative prognostic factor in patients with resected liver metastases. J. Clin. Oncol. 17: 1364-1374
-
(1999)
J. Clin. Oncol.
, vol.17
, pp. 1364-1374
-
-
Sturm, I.1
Kohne, C.H.2
Wolff, G.3
Petrowsky, H.4
Hillebrand, T.5
Hauptmann, S.6
Lorenz, M.7
Dörken, B.8
Daniel, P.T.9
-
16
-
-
0033883376
-
Impaired bax protein expression in breast cancer: Mutational analysis of the bax and the p53 gene
-
Sturm I, Papadopoulos S, Hillebrand T, Benter T, Luck HJ, Wolff G, Dörken B and Daniel PT (2000) Impaired bax protein expression in breast cancer: mutational analysis of the bax and the p53 gene. Int. J. Cancer 87: 517-521
-
(2000)
Int. J. Cancer
, vol.87
, pp. 517-521
-
-
Sturm, I.1
Papadopoulos, S.2
Hillebrand, T.3
Benter, T.4
Luck, H.J.5
Wolff, G.6
Dörken, B.7
Daniel, P.T.8
-
17
-
-
0035871439
-
ink4a/cdkn2 identifies patients with good prognosis
-
ink4a/cdkn2 identifies patients with good prognosis. J. Clin. Oncol. 19: 2272-2281
-
(2001)
J. Clin. Oncol.
, vol.19
, pp. 2272-2281
-
-
Sturm, I.1
Petrowsky, H.2
Volz, R.3
Lorenz, M.4
Radetzki, S.5
Hillebrand, T.6
Wolff, G.7
Hauptmann, S.8
Dörken, B.9
Daniel, P.T.10
-
18
-
-
0036097786
-
Keeping killers on a tight leash: Transcriptional and post-translational control of the pro-apoptotic activity of BH3-only proteins
-
Puthalakath H and Strasser A (2002) Keeping killers on a tight leash: transcriptional and post-translational control of the pro-apoptotic activity of BH3-only proteins. Cell Death Differ. 9: 505-512
-
(2002)
Cell Death Differ.
, vol.9
, pp. 505-512
-
-
Puthalakath, H.1
Strasser, A.2
-
19
-
-
0034640281
-
Noxa, a BH3-only member of the bcl-2 family and candidate mediator of p53-induced apoptosis
-
Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, Yamashita T, Tokino T, Taniguchi T and Tanaka N (2000) Noxa, a BH3-only member of the bcl-2 family and candidate mediator of p53-induced apoptosis. Science 288: 1053-1058
-
(2000)
Science
, vol.288
, pp. 1053-1058
-
-
Oda, E.1
Ohki, R.2
Murasawa, H.3
Nemoto, J.4
Shibue, T.5
Yamashita, T.6
Tokino, T.7
Taniguchi, T.8
Tanaka, N.9
-
20
-
-
0035265686
-
Puma, a novel proapoptotic gene, is induced by p53
-
Nakano K and Vousden KH (2001) Puma, a novel proapoptotic gene, is induced by p53. Mol. Cell 7: 683-694
-
(2001)
Mol. Cell
, vol.7
, pp. 683-694
-
-
Nakano, K.1
Vousden, K.H.2
-
21
-
-
0035821652
-
DNA microarray analysis of genes involved in p53 mediated apoptosis: Activation of APAF-1
-
Kannan K, Kaminski N, Rechavi G, Jakob-Hirsch J, Amariglio N and Givol D (2001) DNA microarray analysis of genes involved in p53 mediated apoptosis: activation of APAF-1. Oncogene 20: 3449-3455
-
(2001)
Oncogene
, vol.20
, pp. 3449-3455
-
-
Kannan, K.1
Kaminski, N.2
Rechavi, G.3
Jakob-Hirsch, J.4
Amariglio, N.5
Givol, D.6
-
22
-
-
0034977277
-
APAF-1 is a transcriptional target for E2F and p53
-
Moroni MC, Hickman ES, Denchi EL, Caprara G, Colli E, Cecconi F, Muller H and Helin K (2001) APAF-1 is a transcriptional target for E2F and p53. Nat. Cell Biol. 3: 552-558
-
(2001)
Nat. Cell Biol.
, vol.3
, pp. 552-558
-
-
Moroni, M.C.1
Hickman, E.S.2
Denchi, E.L.3
Caprara, G.4
Colli, E.5
Cecconi, F.6
Muller, H.7
Helin, K.8
-
23
-
-
0027451668
-
P53-dependent apoptosis modulates the cytotoxicity of anticancer agents
-
Lowe SW, Ruley HE, Jacks T and Housman DE (1993) P53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74: 957-967
-
(1993)
Cell
, vol.74
, pp. 957-967
-
-
Lowe, S.W.1
Ruley, H.E.2
Jacks, T.3
Housman, D.E.4
-
24
-
-
0030029580
-
Novel ex vivo analysis of nonclassical, pleiotropic drug resistance and collateral sensitivity induced by therapy provides a rationale for treatment strategies in chronic lymphocytic leukemia
-
Bosanquet AG and Bell PB (1996) Novel ex vivo analysis of nonclassical, pleiotropic drug resistance and collateral sensitivity induced by therapy provides a rationale for treatment strategies in chronic lymphocytic leukemia. Blood 87: 1962-1971
-
(1996)
Blood
, vol.87
, pp. 1962-1971
-
-
Bosanquet, A.G.1
Bell, P.B.2
-
25
-
-
0034091153
-
Ex vivo assessment of drug response by differential staining cytotoxicity (disc) assay suggests a biological basis for equality of chemotherapy irrespective of age for patients with chronic lymphocytic leukaemia
-
Bosanquet AG and Bosanquet MI (2000) Ex vivo assessment of drug response by differential staining cytotoxicity (disc) assay suggests a biological basis for equality of chemotherapy irrespective of age for patients with chronic lymphocytic leukaemia. Leukemia 14: 712-715
-
(2000)
Leukemia
, vol.14
, pp. 712-715
-
-
Bosanquet, A.G.1
Bosanquet, M.I.2
-
26
-
-
0026561988
-
Mutations of the p53 gene in b-cell chronic lymphocytic leukemia: A report on 39 cases with cytogenetic analysis
-
Fenaux P, Preudhomme C, Lai JL, Quiquandon I, Jonveaux P, Vanrumbeke M, Sartiaux C, Morel P, Loucheux-Lefebvre MH and Bauters F (1992) Mutations of the p53 gene in b-cell chronic lymphocytic leukemia: a report on 39 cases with cytogenetic analysis. Leukemia 6: 246-250
-
(1992)
Leukemia
, vol.6
, pp. 246-250
-
-
Fenaux, P.1
Preudhomme, C.2
Lai, J.L.3
Quiquandon, I.4
Jonveaux, P.5
Vanrumbeke, M.6
Sartiaux, C.7
Morel, P.8
Loucheux-Lefebvre, M.H.9
Bauters, F.10
-
27
-
-
0025951144
-
P53 mutations in human lymphoid malignancies: Association with Burkitt lymphoma and chronic lymphocytic leukemia
-
Gaidano G, Ballerini P, Gong JZ, Inghirami G, Neri A, Newcomb EW, Magrath IT, Knowles DM and Dalla-Favera R (1991) P53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. USA 88: 5413-5417
-
(1991)
Proc. Natl. Acad. Sci. USA
, vol.88
, pp. 5413-5417
-
-
Gaidano, G.1
Ballerini, P.2
Gong, J.Z.3
Inghirami, G.4
Neri, A.5
Newcomb, E.W.6
Magrath, I.T.7
Knowles, D.M.8
Dalla-Favera, R.9
-
28
-
-
0027436745
-
P53 gene mutation in B-cell chronic lymphocytic leukemia is associated with drug resistance and is independent of mdr1/mdr3 gene expression
-
el Rouby S, Thomas A, Costin D, Rosenberg CR, Potmesil M, Silber R and Newcomb EW (1993) P53 gene mutation in B-cell chronic lymphocytic leukemia is associated with drug resistance and is independent of mdr1/mdr3 gene expression. Blood 82: 3452-3459
-
(1993)
Blood
, vol.82
, pp. 3452-3459
-
-
el Rouby, S.1
Thomas, A.2
Costin, D.3
Rosenberg, C.R.4
Potmesil, M.5
Silber, R.6
Newcomb, E.W.7
-
29
-
-
0033869494
-
Role of poly(ADP-ribosyl)ation in the killing of chronic lymphocytic leukemia cells by purine analogues
-
Pettitt AR, Sherrington PD and Cawley JC (2000) Role of poly(ADP-ribosyl)ation in the killing of chronic lymphocytic leukemia cells by purine analogues. Cancer Res. 60: 4187-4193
-
(2000)
Cancer Res.
, vol.60
, pp. 4187-4193
-
-
Pettitt, A.R.1
Sherrington, P.D.2
Cawley, J.C.3
-
30
-
-
0030951813
-
P53 abnormalities in B-cell prolymphocytic leukemia
-
Lens D, De Schouwar PJ, Hamoudi RA, Abdul-Rauf M, Farahat N, Matutes E, Crook T, Dyer MJ and Catovsky D (1997) P53 abnormalities in B-cell prolymphocytic leukemia. Blood 89: 2015-2023
-
(1997)
Blood
, vol.89
, pp. 2015-2023
-
-
Lens, D.1
De Schouwar, P.J.2
Hamoudi, R.A.3
Abdul-Rauf, M.4
Farahat, N.5
Matutes, E.6
Crook, T.7
Dyer, M.J.8
Catovsky, D.9
-
31
-
-
0038075337
-
Combined p53/bax mutation results in extremely poor prognosis in gastric carcinoma with low microsatellite instability
-
Mrozek A, Petrowsky H, Sturm I, Krauss J, Hermann S, Hauptmann S, Lorenz M and Daniel P (2003) Combined p53/bax mutation results in extremely poor prognosis in gastric carcinoma with low microsatellite instability. Cell Death Differ. 10: 461-467
-
(2003)
Cell Death Differ.
, vol.10
, pp. 461-467
-
-
Mrozek, A.1
Petrowsky, H.2
Sturm, I.3
Krauss, J.4
Hermann, S.5
Hauptmann, S.6
Lorenz, M.7
Daniel, P.8
-
32
-
-
0037428655
-
Multigene analysis of Rb-pathway and apoptosis-control in esophageal squamous cell carcinoma identifies patients with good prognosis
-
Güner D, Sturm I, Hemmati PG, Hermann S, Hauptmann S, Wurm R, Budach V, Dörken B, Lorenz M and Daniel PT (2002) Multigene analysis of Rb-pathway and apoptosis-control in esophageal squamous cell carcinoma identifies patients with good prognosis. Int. J. Cancer 103: 445-454
-
(2002)
Int. J. Cancer
, vol.103
, pp. 445-454
-
-
Güner, D.1
Sturm, I.2
Hemmati, P.G.3
Hermann, S.4
Hauptmann, S.5
Wurm, R.6
Budach, V.7
Dörken, B.8
Lorenz, M.9
Daniel, P.T.10
-
33
-
-
0035156737
-
Insights into cancer therapeutic design based on p53 and trail receptor signaling
-
El-Deiry WS (2001) Insights into cancer therapeutic design based on p53 and trail receptor signaling. Cell Death Differ. 8: 1066-1075
-
(2001)
Cell Death Differ.
, vol.8
, pp. 1066-1075
-
-
El-Deiry, W.S.1
-
34
-
-
0035156707
-
P53-dependent pathways of apoptosis
-
Benchimol S (2001) P53-dependent pathways of apoptosis. Cell Death Differ. 8: 1049-1051
-
(2001)
Cell Death Differ.
, vol.8
, pp. 1049-1051
-
-
Benchimol, S.1
-
35
-
-
0035154327
-
DNA damage and apoptosis
-
Wang JY (2001) DNA damage and apoptosis. Cell Death Differ. 8: 1047-1048
-
(2001)
Cell Death Differ.
, vol.8
, pp. 1047-1048
-
-
Wang, J.Y.1
-
36
-
-
0033891414
-
Radiation-induced apoptosis in the adult central nervous system is p53-dependent
-
Chow BM, Li YQ and Wong CS (2000) Radiation-induced apoptosis in the adult central nervous system is p53-dependent. Cell Death Differ. 7: 712-720
-
(2000)
Cell Death Differ.
, vol.7
, pp. 712-720
-
-
Chow, B.M.1
Li, Y.Q.2
Wong, C.S.3
-
37
-
-
0344729013
-
Chlorambucil in indolent chronic lymphocytic leukemia. French cooperative group on chronic lymphocytic leukemia
-
Dighiero G, Maloum K, Desablens B, Cazin B, Navarro M, Leblay R, Leporrier M, Jaubert J, Lepeu G, Dreyfus B, Binet JL and Travade P (1998) Chlorambucil in indolent chronic lymphocytic leukemia. French cooperative group on chronic lymphocytic leukemia. N. Engl. J. Med. 338: 1506-1514
-
(1998)
N. Engl. J. Med.
, vol.338
, pp. 1506-1514
-
-
Dighiero, G.1
Maloum, K.2
Desablens, B.3
Cazin, B.4
Navarro, M.5
Leblay, R.6
Leporrier, M.7
Jaubert, J.8
Lepeu, G.9
Dreyfus, B.10
Binet, J.L.11
Travade, P.12
-
38
-
-
0032563952
-
Secondary acute leukemia in chronic lymphocytic leukemia
-
Grunwald HW and Rosner F (1998) Secondary acute leukemia in chronic lymphocytic leukemia. N. Engl. J. Med. 339: 924
-
(1998)
N. Engl. J. Med.
, vol.339
, pp. 924
-
-
Grunwald, H.W.1
Rosner, F.2
-
39
-
-
0017606940
-
Chronic lymphocytic leukemia terminating in acute leukemia
-
Zarrabi MH, Grunwald HW and Rosner F (1977) Chronic lymphocytic leukemia terminating in acute leukemia. Arch. Intern. Med. 137: 1054-1059
-
(1977)
Arch. Intern. Med.
, vol.137
, pp. 1054-1059
-
-
Zarrabi, M.H.1
Grunwald, H.W.2
Rosner, F.3
-
40
-
-
0026696771
-
P53 mutations in C57BI/6J murine thymic lymphomas induced by gamma-irradiation and n-methylnitrosourea
-
Brathwaite O, Bayona W and Newcomb EW (1992) P53 mutations in C57BI/6J murine thymic lymphomas induced by gamma-irradiation and n-methylnitrosourea. Cancer Res. 52: 3791-3795
-
(1992)
Cancer Res.
, vol.52
, pp. 3791-3795
-
-
Brathwaite, O.1
Bayona, W.2
Newcomb, E.W.3
-
41
-
-
0035132847
-
Evidence for the development of p53 mutations after cytotoxic therapy in a neuroblastoma cell line
-
Tweddle DA, Malcolm AJ, Bown N, Pearson AD and Lunec J (2001) Evidence for the development of p53 mutations after cytotoxic therapy in a neuroblastoma cell line. Cancer Res. 61: 8-13
-
(2001)
Cancer Res.
, vol.61
, pp. 8-13
-
-
Tweddle, D.A.1
Malcolm, A.J.2
Bown, N.3
Pearson, A.D.4
Lunec, J.5
-
43
-
-
0028091651
-
Clinical significance of p53 mutations in relapsed T-cell acute lymphoblastic leukemia
-
Diccianni MB, Yu J, Hsiao M, Mukherjee S, Shao LE and Yu AL (1994) Clinical significance of p53 mutations in relapsed T-cell acute lymphoblastic leukemia. Blood 84: 3105-3112
-
(1994)
Blood
, vol.84
, pp. 3105-3112
-
-
Diccianni, M.B.1
Yu, J.2
Hsiao, M.3
Mukherjee, S.4
Shao, L.E.5
Yu, A.L.6
-
44
-
-
0030664518
-
Exon 5 mutations in the p53 gene in relapsed childhood acute lymphoblastic leukemia
-
Blau O, Avigad S, Stark B, Kodman Y, Luria D, Cohen IJ and Zaizov R (1997) Exon 5 mutations in the p53 gene in relapsed childhood acute lymphoblastic leukemia. Leuk. Res. 21: 721-729
-
(1997)
Leuk. Res.
, vol.21
, pp. 721-729
-
-
Blau, O.1
Avigad, S.2
Stark, B.3
Kodman, Y.4
Luria, D.5
Cohen, I.J.6
Zaizov, R.7
-
45
-
-
0028008553
-
Directional selection associated with clonal expansion of p53 mutant cells during neoplastic development of carcinogen-treated rat embryo lung epithelial cells
-
Le Rhun Y, Duthu A, Ehrhart JC, Michiels F, May E and May P (1994) Directional selection associated with clonal expansion of p53 mutant cells during neoplastic development of carcinogen-treated rat embryo lung epithelial cells. Oncogene 9: 263-271
-
(1994)
Oncogene
, vol.9
, pp. 263-271
-
-
Le Rhun, Y.1
Duthu, A.2
Ehrhart, J.C.3
Michiels, F.4
May, E.5
May, P.6
-
46
-
-
0032844150
-
The effect of p53 dysfunction on purine analogue cytotoxicity in chronic lymphocytic leukaemia
-
Pettitt AR, Sherrington PD and Cawley JC (1999) The effect of p53 dysfunction on purine analogue cytotoxicity in chronic lymphocytic leukaemia. Br. J. Haematol. 106: 1049-1051
-
(1999)
Br. J. Haematol.
, vol.106
, pp. 1049-1051
-
-
Pettitt, A.R.1
Sherrington, P.D.2
Cawley, J.C.3
-
47
-
-
0029978058
-
Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: Relationship between p53 gene mutation and bcl-2/bax proteins in drug resistance
-
Thomas A, El RS, Reed JC, Krajewski S, Silber R, Potmesil M and Newcomb EW (1996) Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: relationship between p53 gene mutation and bcl-2/bax proteins in drug resistance. Oncogene 12: 1055-1062
-
(1996)
Oncogene
, vol.12
, pp. 1055-1062
-
-
Thomas, A.1
El, R.S.2
Reed, J.C.3
Krajewski, S.4
Silber, R.5
Potmesil, M.6
Newcomb, E.W.7
-
48
-
-
0031450247
-
Bcl-2 protein expression and p53 gene mutation in chronic lymphocytic leukemia: Correlation with in vitro sensitivity to chlorambucil and purine analogs
-
Morabito F, Filangeri M, Callea I, Sculli G, Callea V, Fracchiolla NS, Neri A and Brugiatelli M (1997) Bcl-2 protein expression and p53 gene mutation in chronic lymphocytic leukemia: correlation with in vitro sensitivity to chlorambucil and purine analogs. Haematologica 82: 16-20
-
(1997)
Haematologica
, vol.82
, pp. 16-20
-
-
Morabito, F.1
Filangeri, M.2
Callea, I.3
Sculli, G.4
Callea, V.5
Fracchiolla, N.S.6
Neri, A.7
Brugiatelli, M.8
-
49
-
-
0034669944
-
Deoxyadenosine analogs induce programmed cell death in chronic lymphocytic leukemia cells by damaging the DNA and by directly affecting the mitochondria
-
Genini D, Adachi S, Chao Q, Rose DW, Carrera CJ, Cottam HB, Carson DA and Leoni LM (2000) Deoxyadenosine analogs induce programmed cell death in chronic lymphocytic leukemia cells by damaging the DNA and by directly affecting the mitochondria. Blood 96: 3537-3543
-
(2000)
Blood
, vol.96
, pp. 3537-3543
-
-
Genini, D.1
Adachi, S.2
Chao, Q.3
Rose, D.W.4
Carrera, C.J.5
Cottam, H.B.6
Carson, D.A.7
Leoni, L.M.8
-
50
-
-
0032483010
-
Induction of an apoptotic program in cell-free extracts by 2-chloro-2′-deoxyadenosine 5′-triphosphate and cytochrome c
-
Leoni LM, Chao Q, Cottam HB, Genini D, Rosenbach M, Carrera CJ, Budihardjo I, Wang X and Carson DA (1998) Induction of an apoptotic program in cell-free extracts by 2-chloro-2′-deoxyadenosine 5′-triphosphate and cytochrome c. Proc. Natl. Acad. Sci. USA 95: 9567-9571
-
(1998)
Proc. Natl. Acad. Sci. USA
, vol.95
, pp. 9567-9571
-
-
Leoni, L.M.1
Chao, Q.2
Cottam, H.B.3
Genini, D.4
Rosenbach, M.5
Carrera, C.J.6
Budihardjo, I.7
Wang, X.8
Carson, D.A.9
-
51
-
-
0030026934
-
Loss of normal p53 function confers sensitization to taxol by increasing G2/M arrest and apoptosis
-
Wahl AF, Donaldson KL, Fairchild C, Lee FY, Foster SA, Demers GW and Galloway DA (1996) Loss of normal p53 function confers sensitization to taxol by increasing G2/M arrest and apoptosis. Nat. Med. 2: 72-79
-
(1996)
Nat. Med.
, vol.2
, pp. 72-79
-
-
Wahl, A.F.1
Donaldson, K.L.2
Fairchild, C.3
Lee, F.Y.4
Foster, S.A.5
Demers, G.W.6
Galloway, D.A.7
-
52
-
-
0029328641
-
Taxol-induced mitotic block triggers rapid onset of a p53-independent apoptotic pathway
-
Woods CM, Zhu J, McQueney PA, Bollag D and Lazarides E (1995) Taxol-induced mitotic block triggers rapid onset of a p53-independent apoptotic pathway. Mol. Med. 1: 506-526
-
(1995)
Mol. Med.
, vol.1
, pp. 506-526
-
-
Woods, C.M.1
Zhu, J.2
McQueney, P.A.3
Bollag, D.4
Lazarides, E.5
-
53
-
-
0029981025
-
National cancer institute-sponsored working group guidelines for chronic lymphocytic leukemia: Revised guidelines for diagnosis and treatment
-
Cheson BD, Bennett A Grever M, Kay N, Keating MJ, O'Brien S and Rai KR (1996) National cancer institute-sponsored working group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 87: 4990-4997
-
(1996)
Blood
, vol.87
, pp. 4990-4997
-
-
Cheson, B.D.1
Bennett, A.2
Grever, M.3
Kay, N.4
Keating, M.J.5
O'Brien, S.6
Rai, K.R.7
-
54
-
-
0029963932
-
Enhanced ex vivo drug sensitivity testing of chronic lymphocytic leukaemia using refined disc assay methodology
-
Bosanquet AG and Bell PB (1996) Enhanced ex vivo drug sensitivity testing of chronic lymphocytic leukaemia using refined disc assay methodology. Leuk. Res. 20: 143-153
-
(1996)
Leuk. Res.
, vol.20
, pp. 143-153
-
-
Bosanquet, A.G.1
Bell, P.B.2
|